Member Info for cj62

Since the 1st patient dose in the US so we should hopefully get an RNs stating completion and start of next cohort within the next week or so.

At this moment in time I would snap their hand off but I actually think its worth a lot more

Still ramping I see Timster and hasn't your therapist told you to stay off LSE for a number of weeks ?

Icecool I actually think Avacta will spin off the TX business and concentrate on the affimer partnerships etc and IMHO the DX side will be a multi billion business in its own right !!

If somebody had a 7% short that would be approx 20 m shares so good luck to them and I should imagine that would be rather an interesting day if they try to buy them back !!

There you go again Thorn making a complete twat of yourself again. Potash & pre|Cision I suppose they both start with a P and there the similarity ends

Thornogson I am due to see my consultant urologist at the start of next month and its the 1st question I will be asking , will let you know the answer

Avacta turned down an extra £13 m in funding last time and I am quite sure if they wanted another £10m lets say to complete P1b I am sure they would get it in an open offer to PI's only but as has been said on here many times I really dont think funding will be an issue on release of P1a after peer review.

Another thing I am quite sure of is that if Dr Tap see extremely beneficial results coming out of P1a in the US he will be knocking on an awful lot of influential doors.

Yeboha until we have any news the SP is the play thing of traders and shorters I imagine , not pretty but heyho !!!

I think AS actually said no more M&A in the near term with concentration being on the synergies within the existing acquisitions.

Maybe and this is just a maybe , they are refining existing products with Affimers

I was Tel at least they knew what they were talking about !!!

hurst will you stop typing utter crud , you do realise that if there were a sniff of a deal in the offing the city would know first and the sp would be reacting accordingly. i truly hope there will be a deal but what you are posting is utter nonsense similar to your size buying ******.

AS said as much himself on Wednesday , Avacta realise they don't have sufficient funds but want to keep hold of preCISION so may have to partner.

Batten down the hatches for a 12 month wait , Year End P1a data and 6 months into P1b for real fireworks unless of course there is a couple of licence deals on P1a data. Throw in another 6 months for good measure just in case AS was a bit over enthusiastic

Capital access avacta research

Insert the 4 words into google search and go to the research portal, sign in as a journalist and download

This is the type of guy you need to make deals

An entrepreneurial and results-driven Chair, CEO and advisor with 30 years of experience who has led and managed listed and unlisted portfolios ranging from niche, regional businesses to multi-divisional global platform companies.

Track record of consistently delivering strong growth in enterprise value with businesses ranging from low single-digit £m profit through to £120m.

Highly skilled at developing high quality business strategies, managing change and transforming businesses with an entrepreneurial vision.

Considered a dynamic thought leader with the ability to influence, coach and mentor executive and senior management teams to deliver success and returns for investors.

Leadership experience covers pharma and healthcare services, technology and communications.

His awards include European CEO Awards Entrepreneur of the Year 2018 and 2019

O&W you totally misread my post, learn to read.

BV AS said the chance for commercialisation possibilities comes when the full re-out of P1a and seriously grows on efficacy data.

O&W lets wait until the P1a data is presented if its good we really wont have to worry to much as AS said himself that is the point at which the big boys will become very interested. If its absolute crap as you are hoping then we may need to raise funds which might be difficult BUT if its very good as we suspect that shouldn't be a problem.

Did you go too Tel , can we hear your opinion please

Not exactly music to my ears but all good especially dox is dox and its in all the biopsies at significant therapeutic levels. They must find the MTD then so any other theory is debunked and they are prepared to go to 8,9 & 10 and beyond to find it. The team aren't worried about the SP and not prepared to booster it either as they near commercialisation which is being very honest.

Thats it then I must sit on my hands for 12 months and buy when I can. GLA